China medicine is unpopular in the EU, but the plant extracts have broad prospects. On this day, the first traditional Chinese medicine, herbal extracts standardized international symposium was held in Wuhan, China. Participants from all walks of life call for the development of internationally accepted standards. It may be announced soon to meet international market’s demand.

Plant extracts as the key to modern medicine using herbs, the introduction of modern pharmaceutical technology, most products in the field of natural medicine and health products on the market, a huge market, herbs and medicinal products, herbal extracts such as the hot product in the international forum. China, Chinese medicine, as the problem of "identity" is hard to open doors to markets in developed countries, most modern plant extracts, appreciated in Western industrialized countries, has opened a new avenue for Chinese medicine.

Chinese herbal extracts for the management theory of traditional Chinese medicine has unique advantages for development. Please, Chinese herbal extracts on the scale of the energy used in pharmaceutical raw materials suppliers and know-how and the main producing countries of the world in the extract, Germany, Italy, Spain and the like.

Plant extracts of Chinese export products exports to China increased to $ 801.5 per cent, which is 41.92 percent of total exports of traditional Chinese medicine. The European Union and seven years after the transition period of 30 months to April, due to its ownership, China Chinese medicine has not been registered Chinese medicine is a deviation from the European Union. The industry believes that the EU market in real estate, Chinese herbal medicine lacks the possibility of plant extracts.

The elements of plant extracts manufactured in China has reached hundreds of species, including the formation of large-scale production and export of herbal extracts, Ginkgo biloba, green tea extract, ginseng extract. These products have great market share in the west. Extraction facilities in China has made significant progress this year, which significantly improves the concentration of the industry but also companies small and innovative products, developing international market opportunities are low.

For the new emerging industry, it lacks of uniform standards for Chinese herbal extracts. Chinese manufactures are producing products in accordance with the standards and requirements from foreign customers. It is easy to use, but the disadvantages are obvious: if the demand for products from manufacturers is limited, many companies will suffer losses. The number of experts agreed that standards should be the established and it should not have conflicts with international standards. More complex testing techniques and methods of producing extracts need to be taken.Source:http://www.cospcn.com